Loading...
XNASYI
Market cap31mUSD
Dec 24, Last price  
0.77USD
1D
4.59%
1Q
26.90%
IPO
-94.47%
Name

111 Inc

Chart & Performance

D1W1MN
XNAS:YI chart
P/E
—
P/S
0.03
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
11.14%
Rev. gr., 5y
52.95%
Revenues
14.95b
+10.59%
873,837,000959,486,0001,785,970,0003,952,053,0008,203,157,00012,425,902,00013,516,698,00014,948,129,000
Net income
-393m
L-3.87%
-362,681,000-248,580,000-380,091,000-492,394,000-459,038,000-662,967,000-408,503,000-392,693,000
CFO
-447m
L+1,831.77%
-388,646,000-204,372,000-343,017,000-510,192,000-116,777,000-641,936,000-23,152,000-447,244,000
Earnings
Mar 19, 2025

Profile

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
URL
http://gangling.111.com.cn/
IPO date
Sep 12, 2018
Employees
1,657
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
14,948,129
10.59%
13,516,698
8.78%
12,425,902
51.48%
Cost of revenue
15,172,278
14,020,647
13,259,338
Unusual Expense (Income)
NOPBT
(224,149)
(503,949)
(833,436)
NOPBT Margin
Operating Taxes
251
32,434
41,942
Tax Rate
NOPAT
(224,400)
(536,383)
(875,378)
Net income
(392,693)
-3.87%
(408,503)
-38.38%
(662,967)
44.43%
Dividends
Dividend yield
Proceeds from repurchase of equity
223
274
(2,969)
BB yield
-0.34%
-0.22%
2.05%
Debt
Debt current
380,605
178,990
259,658
Long-term debt
167,778
200,938
331,228
Deferred revenue
Other long-term liabilities
5,245
1,536
Net debt
(107,283)
(501,602)
(256,060)
Cash flow
Cash from operating activities
(447,244)
(23,152)
(641,936)
CAPEX
(9,822)
(31,574)
(62,692)
Cash from investing activities
151,743
(47,173)
60,138
Cash from financing activities
205,978
22,735
27,438
FCF
(150,165)
(434,656)
(1,047,412)
Balance
Cash
653,666
879,530
843,946
Long term investments
2,000
2,000
3,000
Excess cash
205,695
225,651
Stockholders' equity
(2,887,123)
(2,288,080)
(1,928,225)
Invested Capital
3,611,701
3,178,041
3,192,803
ROIC
ROCE
EV
Common stock shares outstanding
84,305
83,445
82,933
Price
0.78
-48.68%
1.51
-13.71%
1.75
-49.64%
Market cap
65,336
-48.15%
126,002
-13.18%
145,134
-49.31%
EV
817,608
687,234
911,100
EBITDA
(202,369)
(463,130)
(806,215)
EV/EBITDA
Interest
20,141
13,443
5,488
Interest/NOPBT